Hemoglobin A<sub>1c</sub> Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29674323.
- Also identified by DOI 10.2337/dc17-2419 and PMC identifier 6014540.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In cystic fibrosis (CF), hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) is thought to underestimate glycemia. However, few studies have directly assessed the relationship between HbA<sub>1c</sub> and average glucose in CF. We determined the relationships among glycemic markers-HbA<sub>1c</sub>, fructosamine (FA), glycated albumin (%GA), and 1,5-anhydroglucitol (1,5-AG)-and continuous glucose monitoring (CGM) in CF, hypothesizing that alternate markers would better predict average sensor glucose (ASG) than HbA<sub>1c</sub>. CF participants and a group of healthy control subjects (HCs), ages 6-25 years, wore CGM for up to 7 days. Pearson correlations assessed the relationships between CGM variables and HbA<sub>1c</sub>, FA, %GA, and 1,5-AG. The regression line between HbA<sub>1c</sub> and ASG was compared in CF versus HC. Linear regressions determined whether alternate markers predicted ASG after adjustment for HbA<sub>1c</sub>. CF (<i>n</i> = 93) and HC (<i>n</i> = 29) groups wore CGM for 5.2 ± 1 days. CF participants were 14 ± 3 years of age and 47% were male, with a BMI <i>z</i> score -0.1 ± 0.8 and no different from HCs in age, sex, or BMI. Mean HbA<sub>1c</sub> in CF was 5.7 ± 0.8% (39 ± 9 mmol/mol) vs. HC 5.1 ± 0.2% (32 ± 2 mmol/mol) (<i>P</i> < 0.0001). All glycemic markers correlated with ASG (<i>P</i> ≤ 0.01): HbA<sub>1c</sub> (<i>r</i> = 0.86), FA (<i>r</i> = 0.69), %GA (<i>r</i> = 0.83), and 1,5-AG (<i>r</i> = -0.26). The regression line between ASG and HbA<sub>1c</sub> did not differ in CF versus HC (<i>P</i> = 0.44). After adjustment for HbA<sub>1c</sub>, %GA continued to predict ASG (<i>P</i> = 0.0009) in CF. HbA<sub>1c</sub> does not underestimate ASG in CF as previously assumed. No alternate glycemic marker correlated more strongly with ASG than HbA<sub>1c</sub>. %GA shows strong correlation with ASG and added to the prediction of ASG beyond HbA<sub>1c</sub>. However, we are not advocating use of HbA<sub>1c</sub> for diabetes screening in CF based on these results. Further study will determine whether glycemic measures other than ASG differ among different types of diabetes for a given HbA<sub>1c</sub>.
Medical subject headings
- Biomarkers
- Blood Glucose
- Cystic Fibrosis
- Diabetes Mellitus
- Glycated Hemoglobin
- Mass Screening